TKT and Hepatic fibrosis: Although the most common adverse effects of TK inhibitors including rash, gastrointestinal symptoms, fatigue, edema, and neurological symptoms are generally mild and tolerable for liver fibrosis patients, liver function impairment and even acute liver failure have been observed in some clinical cases.